Vheda Health Achieves I1 HITRUST Certification

2 weeks ago

Reinforcing Its Commitment to Security and Client Trust COLUMBIA, MD / ACCESSWIRE / December 10, 2024 / Vheda Health, a…

Dr. Amir Bajoghli and Team Publish New Case Study on Aquagenic Urticaria in BMJ Journals

2 weeks ago

MCLEAN, VA / ACCESSWIRE / December 10, 2024 / Dr. Amir Bajoghli and his colleagues have recently published an insightful…

Dr. Sindhu Srinivas Joins Ankle & Foot Centers of America

2 weeks ago

A fellowship-trained ankle and foot surgeon and expert in lower-limb salvage, Srinivas will provide a comprehensive range of podiatric services…

Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne

2 weeks ago

- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne --…

MIRA Pharmaceuticals Validates Ketamir-2’s Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End

2 weeks ago

Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain MIAMI, FL / ACCESSWIRE /…

Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product

2 weeks ago

~ Supply Chain Now Fully Secure for PF614-MPAR ~ SAN DIEGO, CA / ACCESSWIRE / December 10, 2024 / Ensysce…

Ignite Biomedical Achieves Key Milestone in Precision Medicine with Successful Analytical Validation of TNF-alpha Inhibitor Treatment Response Predictor

2 weeks ago

Validation Results Pave the Way for Clinical Studies Focused on Transforming Patient Outcomes inInflammatory BowelDisease FRAMINGHAM, MA / ACCESSWIRE /…

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

2 weeks ago

TORONTO, ON / ACCESSWIRE / December 10, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical…

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

2 weeks ago

Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a…

Interactive Strength Inc. (Nasdaq:TRNR) Regains Full Compliance With Nasdaq Continued Listing Standards

2 weeks ago

AUSTIN, TX / ACCESSWIRE / December 10, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative…